PetMed Express Hits New 52-Week Low at $2.63 Amidst Market Struggles

PetMed Express, Inc., a microcap company in the retailing industry, has recently reached a new 52-week low, trading at USD 2.63 on September 22, 2025. This decline marks a significant downturn for the stock, which has experienced a 37.38% decrease over the past year, contrasting sharply with the S&P 500's performance of 16.64% during the same period.
The company's market capitalization stands at USD 59 million, and it currently holds a price-to-earnings (P/E) ratio of 82.00. Notably, PetMed Express has a low debt-to-equity ratio of -0.52, indicating a conservative approach to leverage. However, its return on equity (ROE) is relatively modest at 0.29%, and the price-to-book ratio is 0.61, suggesting a fair valuation in the current market context.

Despite a reported increase in profits of 104.7% over the past year, the stock has consistently underperformed against the S&P 500, generating returns of -21.79% in the last year alone. The company's financial metrics reflect a challenging environment, with operating cash flow and debtor turnover ratios at their lowest levels.